Echo IQ has implemented its AI-based decision support software, EchoSolv AS, at Mount Sinai Health System in New York to aid in assessing severe aortic stenosis. This deployment marks a key milestone in Echo IQ's US commercial strategy, supporting cardiologists with improved diagnostic consistency within routine echocardiography workflows. Mount Sinai, a leading cardiovascular care institution, will use EchoSolv AS to help identify under-diagnosed aortic stenosis cases, potentially improving patient outcomes. Echo IQ plans to expand adoption of this AI tool across other US hospitals and continue developing new products in cardiology AI support.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Rotork PLC has accepted a £4.1 billion takeover bid from Swiss engineering group ABB, offering shareholders 506p per share, a 73% premium over the previous closing price. The acquisition will enhance ABB's industrial automation business by adding Rot...
Alexandria Real Estate Equities (ARE) is struggling with oversupply and vacancy rates exceeding 30% in key life science markets like Boston, San Francisco, and San Diego. This has caused an 80% decline in its stock price from its peak. The company's ...
ASML Holdings has raised its 2026 revenue guidance midpoint from €38 billion to €44 billion and increased its gross margin midpoint from 52% to 55%, reflecting strong growth prospects. The analyst maintains a Buy rating and raises the price target fr...
Labcorp is considered a buy due to its effective rollup strategy in a fragmented lab testing industry, driving steady and predictable growth. Automation is reducing operational costs, helping to counteract healthcare pricing pressures. The company no...
